RxDoctor Payments Data

Rano Faltas, MD

Anesthesiology · Minneapolis, MNNPI 1992060891

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,012 of the $9,047 with a category attached, or 77.5%. 28 manufacturers reported payments, led by Abbott at 28.4% of the total. Reporting peaked in 2024 at $2,244 and has fallen 72.4% since, to $618 in 2025. Among anesthesiology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,047in general payments, 2019–2025

Across 231 payments — averaging $39.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Relievant Medsystems, Inc.$900
  • Boston Scientific$838
  • Nevro Corp.$820
  • Medtronic$795
  • SPR Therapeutics, Inc$643
  • plus $2K from 22 others
$27,343in research payments, 2019–2025

Across 5 payments — averaging $5468.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$27K

What the payments were for

  • Travel & lodging$1,99522%
  • Food & beverage$7,01278%
  • Education$400%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,047 in reported general payments places this provider in the 95th percentile of 736 anesthesiology providers in Minnesota.

See all anesthesiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$150,149
Medicare patients
373
Services billed
1,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin186$2,157
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen182$1,036
Pregabalin63$801
Methocarbamol36$791
Tizanidine Hcl105$757
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen49$707
Amitriptyline Hcl55$558
Methylprednisolone66$477
Cephalexin73$437
Tramadol Hcl45$305
Cyclobenzaprine Hcl28$304
Topiramate31$265
Baclofen28$260
Hydromorphone Hcl23$224
Duloxetine Hcl18$193

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →